Caregen Terminates 37.9B KRW PELO BAUM Supply Contract Due to Counterparty Breach; Revenue Gap Concern

Caregen terminated a supply contract for its new hair loss prevention and growth promotion product 'PELO BAUM' (shampoo, conditioner, solution).
The contract termination amount is approximately 37.95 billion KRW, representing 104.2% of the 2015 annual revenue (36.42 billion KRW), indicating a significant contract.
The termination reason is the counterparty (INNOVAHEALTH, AESTHETICS SOLUTIONS LTD)'s failure to fulfill major obligations; Caregen exercised its termination rights under the contract.
The contract was signed in June 2016 and was expected to run for 10 years, but was terminated early on May 29, 2026.
This termination eliminates anticipated long-term revenue, raising concerns about potential revenue gaps and growth slowdown.
However, relative to Caregen's current market cap (approx. 4.8 trillion KRW), the contract size is not large, so the overall impact on enterprise value may be limited.
[AI Comprehensive Analysis]This contract termination may cause short-term revenue decline and credibility loss, but in the long run, it removes risks from an unreliable partner. Investors should monitor future new contracts and existing business performance.